269 related articles for article (PubMed ID: 26884837)
1. MiR-15b mediates liver cancer cells proliferation through targeting BCL-2.
Zhang Y; Huang F; Wang J; Peng L; Luo H
Int J Clin Exp Pathol; 2015; 8(12):15677-83. PubMed ID: 26884837
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
3. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
4. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
[TBL] [Abstract][Full Text] [Related]
7. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
9. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
Li K; Xyu Q; Liu X; Liu Q; Wang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
[TBL] [Abstract][Full Text] [Related]
10. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
[TBL] [Abstract][Full Text] [Related]
11. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
Li H; Huang W; Luo R
Diagn Pathol; 2015 Jul; 10():117. PubMed ID: 26194496
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
[TBL] [Abstract][Full Text] [Related]
14. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
16. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
17. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
18. miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression.
Zhuang D; Liang L; Zhang H; Feng X
Oncol Res; 2020 Sep; 28(4):399-408. PubMed ID: 32272979
[TBL] [Abstract][Full Text] [Related]
19. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
[TBL] [Abstract][Full Text] [Related]
20. [MiR-503 sensitizes human hepatocellular carcinoma cells to cisplatin by targeting bcl-2].
Yang X; Yin J; Xiang Q; Xie H; Yu J; Gan R; Lei X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):605-610. PubMed ID: 28690214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]